BDBM795183 US12570607, Example 17
SMILES COc1ccccc1-c1cc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)ncc1F
InChI Key
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 7 hits for monomerid = 795183
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 7.12nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 193nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 5(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 357nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 474nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 1.44E+3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 6(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 3.17E+3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 7(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 5.48E+3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
